久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/05/25 | 3,780 | 3,805 | 3,765 | 3,795 | +15 | +0.4% | 97,700 |
| 2023/05/24 | 3,785 | 3,805 | 3,765 | 3,780 | -5 | -0.1% | 60,600 |
| 2023/05/23 | 3,820 | 3,820 | 3,765 | 3,785 | -20 | -0.5% | 59,700 |
| 2023/05/22 | 3,780 | 3,815 | 3,775 | 3,805 | +25 | +0.7% | 52,200 |
| 2023/05/19 | 3,790 | 3,790 | 3,765 | 3,780 | -20 | -0.5% | 85,600 |
| 2023/05/18 | 3,820 | 3,820 | 3,775 | 3,800 | -5 | -0.1% | 99,500 |
| 2023/05/17 | 3,800 | 3,830 | 3,800 | 3,805 | -5 | -0.1% | 88,600 |
| 2023/05/16 | 3,800 | 3,815 | 3,785 | 3,810 | +25 | +0.7% | 86,600 |
| 2023/05/15 | 3,780 | 3,790 | 3,755 | 3,785 | +30 | +0.8% | 72,300 |
| 2023/05/12 | 3,735 | 3,765 | 3,715 | 3,755 | +15 | +0.4% | 122,700 |
| 2023/05/11 | 3,765 | 3,780 | 3,730 | 3,740 | -70 | -1.8% | 112,100 |
| 2023/05/10 | 3,820 | 3,820 | 3,785 | 3,810 | -20 | -0.5% | 116,200 |
| 2023/05/09 | 3,790 | 3,830 | 3,790 | 3,830 | +45 | +1.2% | 101,000 |
| 2023/05/08 | 3,765 | 3,790 | 3,760 | 3,785 | +20 | +0.5% | 120,900 |
| 2023/05/02 | 3,790 | 3,795 | 3,755 | 3,765 | ±0 | ±0% | 101,000 |
| 2023/05/01 | 3,780 | 3,805 | 3,765 | 3,765 | +15 | +0.4% | 109,700 |
| 2023/04/28 | 3,735 | 3,760 | 3,725 | 3,750 | +65 | +1.8% | 172,100 |
| 2023/04/27 | 3,680 | 3,700 | 3,670 | 3,685 | -35 | -0.9% | 172,800 |
| 2023/04/26 | 3,675 | 3,725 | 3,655 | 3,720 | +40 | +1.1% | 174,200 |
| 2023/04/25 | 3,705 | 3,715 | 3,670 | 3,680 | ±0 | ±0% | 93,400 |
| 2023/04/24 | 3,720 | 3,720 | 3,670 | 3,680 | -5 | -0.1% | 76,300 |
| 2023/04/21 | 3,710 | 3,715 | 3,680 | 3,685 | -25 | -0.7% | 122,700 |
| 2023/04/20 | 3,690 | 3,720 | 3,665 | 3,710 | +15 | +0.4% | 102,800 |
| 2023/04/19 | 3,720 | 3,720 | 3,685 | 3,695 | ±0 | ±0% | 79,800 |
| 2023/04/18 | 3,680 | 3,730 | 3,675 | 3,695 | +35 | +1% | 105,200 |
| 2023/04/17 | 3,730 | 3,760 | 3,655 | 3,660 | -80 | -2.1% | 183,000 |
| 2023/04/14 | 3,720 | 3,770 | 3,715 | 3,740 | -90 | -2.3% | 194,000 |
| 2023/04/13 | 3,805 | 3,845 | 3,780 | 3,830 | +40 | +1.1% | 166,000 |
| 2023/04/12 | 3,790 | 3,800 | 3,765 | 3,790 | +55 | +1.5% | 81,200 |
| 2023/04/11 | 3,760 | 3,785 | 3,725 | 3,735 | +5 | +0.1% | 101,000 |
| 2023/04/10 | 3,765 | 3,780 | 3,715 | 3,730 | -20 | -0.5% | 90,500 |
| 2023/04/07 | 3,750 | 3,770 | 3,740 | 3,750 | -40 | -1.1% | 83,400 |
| 2023/04/06 | 3,745 | 3,795 | 3,730 | 3,790 | +30 | +0.8% | 115,800 |
| 2023/04/05 | 3,855 | 3,855 | 3,745 | 3,760 | -100 | -2.6% | 104,400 |
| 2023/04/04 | 3,820 | 3,860 | 3,795 | 3,860 | +15 | +0.4% | 143,800 |
| 2023/04/03 | 3,840 | 3,855 | 3,815 | 3,845 | +65 | +1.7% | 97,200 |
| 2023/03/31 | 3,780 | 3,795 | 3,750 | 3,780 | +35 | +0.9% | 160,300 |
| 2023/03/30 | 3,795 | 3,800 | 3,730 | 3,745 | -30 | -0.8% | 83,900 |
| 2023/03/29 | 3,725 | 3,775 | 3,705 | 3,775 | +85 | +2.3% | 133,500 |
| 2023/03/28 | 3,725 | 3,730 | 3,670 | 3,690 | ±0 | ±0% | 60,300 |
| 2023/03/27 | 3,685 | 3,710 | 3,675 | 3,690 | +25 | +0.7% | 104,400 |
| 2023/03/24 | 3,615 | 3,670 | 3,610 | 3,665 | +20 | +0.5% | 94,600 |
| 2023/03/23 | 3,635 | 3,650 | 3,605 | 3,645 | -50 | -1.4% | 101,400 |
| 2023/03/22 | 3,710 | 3,715 | 3,665 | 3,695 | +55 | +1.5% | 144,000 |
| 2023/03/20 | 3,710 | 3,715 | 3,630 | 3,640 | -90 | -2.4% | 119,600 |
| 2023/03/17 | 3,720 | 3,740 | 3,700 | 3,730 | +35 | +0.9% | 149,900 |
| 2023/03/16 | 3,640 | 3,700 | 3,630 | 3,695 | -15 | -0.4% | 121,900 |
| 2023/03/15 | 3,695 | 3,710 | 3,670 | 3,710 | +40 | +1.1% | 131,400 |
| 2023/03/14 | 3,660 | 3,690 | 3,595 | 3,670 | -55 | -1.5% | 176,500 |
| 2023/03/13 | 3,775 | 3,775 | 3,695 | 3,725 | -80 | -2.1% | 134,700 |
551～
600
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 428,400円 | +5.8% | +1.2% | 2.80% | 13.87倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 140,700円 | -11.0% | +206.6% | 0.00% | 13.97倍 | 3.30倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 156,700円 | -2.0% | -7.3% | 2.43% | 15.32倍 | 1.82倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 361,300円 | +3.8% | -19.9% | 3.76% | 11.74倍 | 0.90倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 322,200円 | +3.6% | -15.3% | 3.85% | 9.05倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
